vTv Therapeutics Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with Type 1 Diabetes
vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of cadisegliatin (TTP399) as an adjunctive therapy to insulin for the treatment of type 1 diabetes (“T1D”), today announced the submission of the study protocol to the FDA…
Koning Health Achieves UAE Regulatory Clearance, Paving the Way for Breast CT Commercialization in the Middle East
Koning Health, a pioneering medical imaging company, is thrilled to announce that it has received regulatory clearance from the Federal Authority for Nuclear Regulation (FANR) in the United Arab Emirates (UAE), marking a significant milestone in the company’s expansion and its commitment…
READY. SET. ROCKIT. BACK TO SCHOOL
Innovative snack sized apple company, Rockit Global is gearing up to inspire millions of consumers across GCC countries to Ready. Set. Rockit. Back to School during its peak sales period. This builds on the Ready. Set. Rockit. campaign – where…
